BioPharma Credit PLC
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BOPCF research report →
About the company
Operating as an investment trust, BioPharma Credit PLC primarily allocates its capital to debt instruments that generate interest. The security for these investments is provided by royalties or other cash streams originating from the commercial sale of approved life sciences products. This company was established in 2016 and its headquarters are situated in Exeter, United Kingdom.
- CEO
- Pedro Gonzalez de Cosio
- IPO
- 2018
- HQ
- Exeter, GB
Price Chart
- Market Cap
- $1.09B
- P/E
- 8.41
- P/S
- 7.67
- P/B
- 0.94
- EV/EBITDA
- 8.18
- Div Yield
- 10.38%
- Gross Margin
- 93.51%
- Op Margin
- 92.51%
- Net Margin
- 92.62%
- ROE
- 11.29%
- ROIC
- 11.24%
- Revenue
- $140.23M · 12.67%
- Net Income
- $129.89M · 6.31%
- EPS
- $0.11 · 10.00%
- Op Income
- $129.85M
- FCF YoY
- -18.60%
- 52W High
- $1.02
- 52W Low
- $0.85
- 50D MA
- $0.93
- 200D MA
- $0.93
- Beta
- 0.18
- Avg Volume
- 257.30K
Get TickerSpark's AI analysis on BOPCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our BOPCF coverage
Recent articles, reports, and earnings notes.
No research on BOPCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BOPCF report →Similar companies
Peers in the same neighborhood.